Use of Complementary and Alternative Therapies in Epilepsy, Cause for Concern
Arch Neurol 62:1472-1475, Pearl,P.L.,et al, 2005
Role for Complementary and Alternative Treatments in Epilepsy
Arch Neurol 62:1471-1472,1475, Scheller,J., 2005
Neurologic Spectrum of Chronic Liver Failure and Basal Ganglia T1 Hyperintensity on Magnetic Resonance Imaging, Probably Manganese Neurotoxicity
Arch Neurol 62:1385-1390, Klos,K.J.,et al, 2005
Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
Arch Neurol 62:1377-1381, Dodd,M.L.,et al, 2005
Recent Use of Oral Contraceptives and the Risk of Multiple Sclerosis
Arch Neurol 62:1362-1365, Alonso,A.,et al, 2005
The "Electrocuted" Hippocampus
Lancet 366:956-957, Uncini,A.,et al, 2005
Cerebral MR Imaging in Uninfected Children Born to HIV-Seropositive Mothers and Perinatally Exposed to Zidovudine
AJNR 26:695-701,687, Tardieu,M.,et al, 2005
Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005
Body Fat Distribution and Long-Term Risk of Stroke Mortality
Stroke 36:1021-1025, Tanne,D.,et al, 2005
Management of Depression After Stroke
Stroke 36:1092-1097, Hackett,M.L.,et al, 2005
Physical Methods for Preventing Deep Vein Thrombosis in Stroke
Stroke 36:1102-1103, Grandi,F.C.,et al, 2005
FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005
The Neurologist and Patient Safety
Neurologist 11:140-149, Glick,T.H., 2005
Spinal MR Findings in Continuous Epidural Analgesia Without Infection
AJNR 26:991-995,987, Ikushima,I.,et al, 2005
Prevalence of Leukoencephalopathy in Children Treated for Acute Lymphoblastic Leukemia with High-Dose Methotrexate
AJNR 26:1263-1269, Reddick,W.E.,et al, 2005
Nonarteritic Ischemic Optic Neuropathy Developing Soon After Use of Sildenafil (Viagra): A Report of Seven New Cases
J Neuroophthalmol 25:9-13, Pomeranz,H. &Bhavsar,A.R., 2005
Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances
Dept Health & Human Services (Apr), FDA Public Health Advisory, 2005
Psychiatric Side Effects During Methysergide Treatment
JNNP 76:1037-1038, Cittadini,E. &Goadsby,P.J., 2005
Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis
JAMA 293:2496-2500, Levin,L.I.,et al, 2005
Effect of Stress Related to the 9/11/2001 Terror Attack on Seizures in Patients with Epilepsy
Neurol 64:1815-1816, Klein,P. &van Passel,L., 2005
Incidence of Contrast Nephropathy From Cerebral CT Angiography and CT Perfusion Imaging
Neurol 64:1805-1806, Josephson,S.A.,et al, 2005
Respiratory Adverse Events Associated with Diazepam Rectal Gel
Neurol 64:1768-1770, Pellock,J.M. &Shinnar,S., 2005
Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis
NEJM 352:1305-1316, 1368, Chimowitz,M.I.,et al, 2005
Ximelagatran vs Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
JAMA 293:690-698,736, SPORTIF Executive Steering Committee for the SPORTIF V Investigators, 2005
Maternal and Infant Characteristics Associated with Perinatal Arterial Stroke in the Infant
JAMA 293:723-729, Lee,J.,et al, 2005
Ximelagatran--Promises and Concerns
JAMA 293:736-739, Gurewich,V., 2005
Role of Cerebral Amyloid Angiopathy in Intracerebral Hemorrhage in Hypertensive Patients
Neurol 64:1233-1237, Ritter,M.A.,et al, 2005
Cellular Telephones and Risk for Brain Tumors
Neurol 64:1189-1195, Christensen,H.C.,et al, 2005
Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in New Users of Antiepileptics
Neurol 64:1134-1138, Mockenhaupt,M.,et al, 2005
Adding Aspirin to Clopidogrel After TIA and Ischemic Stroke
Neurol 64:1117-1121, Hankey,G.J. &Eikelboom,J.W., 2005
Gadolinium Encephalopathy in a Patient with Renal Failure
Neurol 64:1276-1278, Maramattom,B.V.,et al, 2005
Increased Rate of Major Malformations in Offspring Exposed to Valproate Durng Pregnancy
Neurol 64:961-965, 938, Wyszynski,D.F., et al, 2005
Lamotrigine and the Risk of Malformations in Pregnancy
Neurol 64:955-960, 938, Cunnington, M. , et al, 2005
Neuropsychological Effects of Exposure to Anticonvulsant Medication in Utero
Neurol 64:949-954, 938, Vinten,J., et al, 2005
Morphine, Gabapentin, or Their Combination for Neuropathic Pain
NEJM 352:1324-1334, 1373, Gilron,I.,et al, 2005
Chronic Inflammatory Demyelinating Polyneuropathy
NEJM 352:1343-1356, Koller,H.,et al, 2005
Clinicopath Conf, Human Granulocytic Ehrlichiosis
NEJM 352:1358-1364, Case 10-2005, 2005
Recurrent Stroke Associated with Cannabis Use
JNNP 76:435-437, Mateo,I.,et al, 2005
Blood Pressure Control and Risk of Stroke
Stroke 36:725-730, Li,C.,et al, 2005
Safety and Efficacy of Endovascular Treatment of Carotid Artery Stenosis Compared with Carotid Endarterectomy
Stroke 36:905-911, Coward,L.J., et al, 2005
Continued Use of Zonisamide Following Development of Renal Calculi
Neurol 64:763-764, Richards, K.C., et al, 2005
Risk of Ischaemic Stroke in People With Migraine: Systemic Review and Meta-analysis of Observational Studies
BMJ 330:63-65, 54, Etminan,M.,et al, 2005
Homocysteine and Stroke: Evidence on a Causal Link From Mendelian Randomisation
Lancet 365:224-232, 194, Casas, J.P., et al, 2005
Association Between Hormone Replacement Therapy and Subsequent Stroke: A Meta-analysis
BMJ 330:342-345, Bath, P.M.W. & Gray, L.J., 2005
Effects of Topiramate and Gabapentin on Cognitive Abilities in Healthy Volunteers
Neurol 64:792-798, Salinsky, M.D., et al, 2005
Timing of TIAs Preceding Stroke
Neurol 64:817-820, Rothwell, P.M. & Warlow, C.P., 2005
Treatment of Early Onset Multiple Sclerosis With Subcutaneous Interferon Beta-1a
Neurol 64:888-890, 778, Pohl,D., et al, 2005
"Levodopa Phobia": A New Iatrogenic Cause of Disability in Parkinson Disease
Neurol 64:923-924, Kurlan, R., 2005
Atypical Antipsychotic Drugs and Risk of Ischaemic Stroke: Population Based Retrospective Cohort Study
BMJ 330:445-448, Gill,S.S., et al, 2005
The Serotonin Syndrome
NEMJ 352:1112-20, Boyer, E.W. & Shannon, M., 2005